細胞増殖製品の世界市場：試薬、培地、フローサイトメーター、遠心分離機、バイオリアクター...市場調査レポートについてご紹介

1 Introduction (Page No. – 18)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Market Segmentation
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitation
1.5 Market Stakeholders

2 Research Methodology (Page No. – 21)
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Share Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.4 Assumptions for the Study

3 Executive Summary (Page No. – 29)
3.1 Introduction
3.2 Current Scenario
3.3 Future Outlook
3.4 Conclusion

4 Premium Insights (Page No. – 35)
4.1 Market Overview
4.2 Market, By Product
4.3 Geographic Analysis: Market, By Cell Type
4.4 Market, By Application
4.5 Geographical Snapshot of the Market
4.6 Lifecycle Analysis, By Region, 2016

5 Market Overview (Page No. – 41)
5.1 Introduction
5.2 Market Segmentation
5.3 Market Dynamics
5.3.1 Drivers
5.3.1.1 Increasing Incidence of Chronic Diseases
5.3.1.2 Rising Government Investments for Cell-Based Research
5.3.1.3 Increasing Initiatives By Companies for Research and Development of Cell-Based Therapies
5.3.1.4 Increasing Number of GMP-Certified Cell Therapy Production Facilities
5.3.2 Restraints
5.3.2.1 High Cost of Cell-Based Research
5.3.2.2 Ethical Concerns Regarding Research on Cell Biology
5.3.3 Opportunities
5.3.3.1 Emerging Countries to Present High-Growth Opportunities
5.3.3.2 3D Cell Expansion Technology: A New Opportunity
5.3.4 Challenge
5.3.4.1 Survival of Small Players and New Entrants

6 Cell Expansion Market, By Product (Page No. – 52)
6.1 Introduction
6.2 Consumables
6.2.1 Reagents, Media, and Serum
6.2.2 Disposables
6.2.2.1 Tissue Culture Flasks
6.2.2.2 Bioreactor Accessories
6.2.2.3 Other Disposables
6.3 Instruments
6.3.1 Cell Expansion Supporting Equipment
6.3.1.1 Flow Cytometers
6.3.1.2 Centrifuges
6.3.1.3 Cell Counters
6.3.1.4 Other Supporting Equipment
6.3.2 Bioreactors
6.3.2.1 Microcarrier Bioreactors
6.3.2.1.1 Microcarrier-Based Anchorage-Dependent Bioreactors
6.3.2.1.2 Suspension-Based Anchorage Independent Bioreactors
6.3.2.2 Perfusion/Hollow Fiber Bioreactors
6.3.3 Automated Cell Expansion Systems

7 Cell Expansion Market, By Cell Type (Page No. – 74)
7.1 Introduction
7.2 Human Cells
7.2.1 Stem Cells
7.2.1.1 Adult Stem Cells
7.2.1.2 Induced Pluripotent Stem Cells
7.2.1.3 Embryonic Stem Cells
7.2.2 Differentiated Cells
7.3 Animal Cells

8 Cell Expansion Market, By Application (Page No. – 85)
8.1 Introduction
8.2 Regenerative Medicine and Stem Cell Research
8.3 Cancer and Cell-Based Research
8.4 Others

9 Cell Expansion Market, By End User (Page No. – 90)
9.1 Introduction
9.2 Research Institutes
9.3 Biopharmaceutical and Biotechnology Companies
9.4 Cell Banks
9.5 Others

10 Cell Expansion Market, By Region (Page No. – 96)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Rest of Asia
10.5 Rest of the World

11 Competitive Landscape (Page No. – 145)
11.1 Overview
11.2 Market Share Analysis
11.3 Competitive Situation and Trends
11.3.1 New Product Launches
11.3.2 Agreements and Collaborations
11.3.3 Expansions
11.3.4 Acquisitions
11.3.5 Other Developments

12 Company Profiles (Page No. – 153)
(Business Overview, Products, Company Snapshot, Recent Developments, MnM View)*
12.1 Introduction
12.2 Thermo Fisher Scientific, Inc.
12.3 GE Healthcare (A Wholly Owned Subsidiary of General Electric Company)
12.4 Lonza Group Ltd.
12.5 Becton, Dickinson and Company
12.6 Corning, Inc.
12.7 Merck KGAA
12.8 Beckman Coulter, Inc. (Subsidiary of Danaher Corporation)
12.9 Miltenyi Biotec
12.10 Stemcell Technologies
12.11 Terumo BCT, Inc. (A Subsidiary of Terumo Corporation)

*Details on Company Financial Might Not Be Captured in Case of Unlisted Companies

13 Appendix (Page No. – 181)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports